Medindia

X

Best Practice Database Supports Bio-Pharma Product Launch

Tuesday, August 12, 2008 General News J E 4
Advertisement
CHAPEL HILL, N.C., Aug. 12 Bio-Pharma executives areincreasingly finding value in the research products and services offered byBest Practices, LLC and in particular in use of the on-demand benchmarkrepository known as the Best Practice Database. (www.BestPracticeDatabase.com)Although documents from the database may be accessed and downloadedindividually, many commercial and operations leaders have come to findoutstanding value in membership to the database which not only provides fullaccess to all content as needed, but also includes services such as newresearch alerts, invitations to participate in topical new studies and ongoingadvisory services to address research needs.

A series of six case study analogs recently published to the databasereview various aspects of product launch, providing unique perspectives forunderstanding the strategies and tactics utilized by top bio-pharma companiesto address commercial issues surrounding their products. One study, "FlomaxCase Study: Evolving Disease State Awareness to Succeed with New Method ofAction," reviews the strategy and tactics utilized by Boehringer-Ingelheim forthe BPH (Benign Prostatic Hyperplasia) indicated product, Flomax/Tamsulosin,to differentiate the product and to boost disease awareness to expand theproduct market. By carving out a niche as a BPH-specific drug and motivating alarge untapped patient pool through multiple communication tactics, Flomaxachieved blockbuster status. Executives and managers can use this research togain insights into methods for differentiating a product and creatingeffective communication tactics to boost awareness and sales of a new product.

For a complimentary summary from this case study, found in the BestPractice Database, "Flomax Case Study: Evolving Disease State Awareness toSucceed with New Method of Action," click on the following link:http://www3.best-in-class.com/dr330.htm.

For more information on this study or the Best Practice Database, contactRobert Naylor at rnaylor@best-in-class.com or (919) 767-9244. Interestedparties may sign-up for a customized tour of the database via the followingURL: http://www3.best-in-class.com/dw212.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profoundprinciple that organizations can chart a course to superior economicperformance by studying the best business practices, operating tactics andwinning strategies of world-class companies. For more than 15 years, ourhighly credentialed research staff has conducted primary research exclusivelyfor our Fortune 500 client base.Key topic areas in the research include: -- Market Entry Strategy -- Using Science to Differentiate -- Using Safety and Cost for Product Positioning -- Disease Awareness -- Physician Communications -- Patient Communications -- Overall Market Outreach -- Potential Market-Entry Strategies for New Products Metrics included in this report are: -- Lifecycle Timeline -- BPH Product Sales 1998-2006 -- BPH Market Leader Sales 1998-2006 -- Flomax DTC Spending 1999-2006

SOURCE Best Practices, LLC
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cell Therapeutics Announces that the European Orga...
S
Sales Contracts Worth $2.3 Million Signed Since 1 ...